Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details)

v3.21.2
SUBSEQUENT EVENTS (Details) - USD ($)
$ in Thousands
9 Months Ended
Oct. 21, 2021
Oct. 15, 2021
Sep. 30, 2021
Sep. 30, 2020
Subsequent Event [Line Items]        
Paid-in-kind interest payment on notes     $ 1,680 $ 0
Subsequent Event        
Subsequent Event [Line Items]        
Paid-in-kind interest payment on notes   $ 1,800    
Increase in principal amount of notes for paid-in-kind interest   $ 1,800    
Principal amount of debt converted $ 45,300      
Subsequent Event | Common Stock        
Subsequent Event [Line Items]        
Shares issued in debt conversion (in shares) 6,533,532      
Subsequent Event | Aptar | Common Stock        
Subsequent Event [Line Items]        
Shares issued for proceeds related to the closing of FDA Letter Milestone (in shares)   235,796    
Proceeds related to the closing of FDA Letter Milestone   $ 1,000